シンバイオ製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4582/E24682 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/06/26 | 日証協 | 783,400株 | -10.48% | 25,700株 | +91.79% | 690,071株 | -7.93% | 36,400株 | +114.12% |
2015/06/19 | 日証協 | 875,100株 | -2.54% | 13,400株 | +67.5% | 749,473株 | +1.01% | 17,000株 | +38.21% |
2015/06/12 | 日証協 | 897,900株 | -7.48% | 8,000株 | -83.23% | 741,973株 | -3.45% | 12,300株 | -58.02% |
2015/06/05 | 日証協 | 970,500株 | +4.14% | 47,700株 | +18.66% | 768,473株 | +1.14% | 29,300株 | +114.78% |
2015/05/29 | 日証協 | 931,900株 | 0% | 40,200株 | 0% | 759,774株 | 0% | 13,642株 | 0% |
2015/05/15 | 日証協 | 1,126,200株 | +5.67% | 90,200株 | +158.45% | 878,350株 | +5.46% | 47,200株 | +78.11% |
2015/05/08 | 日証協 | 1,065,800株 | +2.4% | 34,900株 | +3.87% | 832,850株 | +2.7% | 26,500株 | -2.21% |
2015/05/01 | 日証協 | 1,040,800株 | +2.24% | 33,600株 | -84.49% | 810,950株 | +2.35% | 27,100株 | -40.57% |
2015/04/24 | 日証協 | 1,018,000株 | -4.48% | 216,600株 | +503.34% | 792,350株 | -6.56% | 45,600株 | +188.61% |
2015/04/17 | 日証協 | 1,065,800株 | -13.63% | 35,900株 | +844.74% | 847,950株 | -3.56% | 15,800株 | -82.41% |
2015/04/10 | 日証協 | 1,234,000株 | +1.28% | 3,800株 | -95.57% | 879,250株 | -2.41% | 89,800株 | +168.86% |
2015/04/03 | 日証協 | 1,218,400株 | +3.57% | 85,753株 | +8.41% | 900,950株 | +3.56% | 33,400株 | -4.03% |
2015/03/20 | 日証協 | 1,172,300株 | -2.16% | 17,500株 | 0% | 850,649株 | -0.56% | 26,600株 | +45.36% |
2015/03/13 | 日証協 | 1,198,200株 | -0.36% | 0株 | -100% | 855,449株 | +2.52% | 18,300株 | -69.19% |
2015/03/06 | 日証協 | 1,202,500株 | +15.02% | 100,000株 | -62.96% | 834,449株 | +11.16% | 59,400株 | -48.75% |
2015/02/27 | 日証協 | 1,045,500株 | +10.98% | 270,000株 | +121.49% | 750,649株 | +10.49% | 115,900株 | +160.92% |
2015/02/20 | 日証協 | 942,100株 | +13.3% | 121,900株 | +116.13% | 679,369株 | +9.62% | 44,420株 | +15.98% |
2015/02/13 | 日証協 | 831,500株 | +0.27% | 56,400株 | -66.65% | 619,749株 | +0.88% | 38,300株 | -34.42% |
2015/02/06 | 日証協 | 829,300株 | +19.75% | 169,100株 | +23.16% | 614,349株 | +12.92% | 58,400株 | -11.52% |
※株式分割は考慮していませんのでご注意ください。
Page Top